1. Home
  2. NTR vs NTRA Comparison

NTR vs NTRA Comparison

Compare NTR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$71.62

Market Cap

34.2B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.07

Market Cap

28.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTR
NTRA
Founded
2017
2003
Country
Canada
United States
Employees
25100
6140
Industry
Agricultural Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
28.2B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
NTR
NTRA
Price
$71.62
$197.07
Analyst Decision
Buy
Strong Buy
Analyst Count
22
15
Target Price
$75.45
$259.07
AVG Volume (30 Days)
2.6M
1.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
2.95%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
$4.03
$18.08
Revenue Next Year
N/A
$19.65
P/E Ratio
$18.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$53.03
$131.81
52 Week High
$85.36
$256.36

Technical Indicators

Market Signals
Indicator
NTR
NTRA
Relative Strength Index (RSI) 47.41 47.22
Support Level $68.97 $187.27
Resistance Level $73.31 $204.34
Average True Range (ATR) 2.05 10.92
MACD -0.05 -1.51
Stochastic Oscillator 38.54 32.72

Price Performance

Historical Comparison
NTR
NTRA

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: